RAN-LABEL UPDATES
RAN-MONTELUKAST is transitioning to TARO-MONTELUKAST; product with the new TARO label will be available in 2021. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change. click here
RAN-AMLODIPINE is transitioning to TARO-AMLODIPINE; product with the new TARO label will be available in 2021. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change. click here
RAN-CYPROTERONE/ETHINYL ESTRADIOL is transitioning to TARO-CYPROTERONE/ETHINYL ESTRADIOL; product with the new TARO label will be available in 2020. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change. click here
RAN-PRAVASTATIN is transitioning to TARO-PRAVASTATIN; product with the new TARO label will be available in 2020. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change.click here
RAN-RABEPRAZOLE is transitioning to TARO-RABEPRAZOLE; product with the new TARO label will be available in 2020. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change. click here
RAN-CLOPIDOGREL is transitioning to TARO-CLOPIDOGREL; product with the new TARO label will be available in 2020. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change. click here
RAN-GABAPENTIN is transitioning to TARO-GABAPENTIN; product with the new TARO label will be available in 2020. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change. click here
RAN-ZOPICLONE is transitioning to TARO-ZOPICLONE; product with the new TARO label will be available in 2020. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change. click here
RAN-PREGABALIN is transitioning to TARO-PREGABALIN; product with the new TARO label will be available in 2020. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change.click here
RAN-VENLAFAXINE XR is transitioning to TARO-VENLAFAXINE XR; product with the new TARO label will be available in 2020. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change.click here
RAN-CANDESARTAN is transitioning to TARO-CANDESARTAN; product with the new TARO label will be available in 2020. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change.click here
RAN-CIPROFLOX is transitioning to TARO-CIPROFLOX; product with the new TARO label will be available in 2020. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change. click here
RAN-DONEPEZIL is transitioning to TARO-DONEPEZIL; product with the new TARO label will be available in 2020. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change. click here
RAN-GLICLAZIDE MR is transitioning to TARO-GLICLAZIDE MR; product with the new TARO label will be available in 2020. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change.click here
RAN-IRBESARTAN is transitioning to TARO-IRBESARTAN; product with the new TARO label will be available in 2020. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change.click here
RAN-VALSARTAN is transitioning to TARO-VALSARTAN; product with the new TARO label will be available in 2020. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change. click here
RAN-LANSOPRAZOLE is transitioning to TARO-LANSOPRAZOLE; product with the new TARO label will be available in 2020. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change. click here
RAN-RAMIPRIL is transitioning to TARO-RAMIPRIL; product with the new TARO label will be available early in 2020. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change. click here
RAN-ATENOLOL is transitioning to TARO-ATENOLOL; product with the new TARO label will be available in 2020. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change.click here
RAN-BUPROPION XL is transitioning to TARO-BUPROPION XL; product with the new TARO label will be available early in 2020. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change. click here
RAN-CEFPROZIL is transitioning to TARO-CEFPROZIL; product with the new TARO label will be available early in 2020. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change. click here
RAN-RAMIPRIL HCTZ is transitioning to TARO-RAMIPRIL HCTZ; product with the new TARO label will be available early in 2020. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change click here
RAN-SIMVASTATIN is transitioning to TARO-SIMVASTATIN; product with the new TARO label will be available in 2020. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change. click here
RAN-ATORVASTATIN is transitioning to TARO-ATORVASTATIN; product with the new TARO label will be available early in 2020. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change. click here
RAN-CEFPROZIL ORAL SUSPENSION is transitioning to TARO-CEFPROZIL ORAL SUSPENSION; product with the new TARO label will be available early in 2020. For this product the DINs, UPCs and formulations will remain the same, only the prefix will change. click here
RAN-ROSUVASTATIN is transitioning to TARO-ROSUVASTATIN; product with the new TARO label will be available early in 2020. For this product the DINs will remain the same, however, the tablet formulation and appearance will change. Bottles of 90 will be replaced with bottles of 100 and UPCs will change. click here
RAN-SOLIFENACIN is transitioning to TARO-SOLIFENACIN; product with the new TARO label will be available early in 2020. For this product the DINs, UPCs, markings and formulations will remain the same, only the prefix will change. click here